Fetal surgery for myelomeningocele: Progress and perspectives

Developmental Medicine and Child Neurology

Volumn 54, Issue 1, 2012, Pages 8-14

  Danzer, Enrico ^a   Johnson, Mark P ^a   Adzick, N Scott ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COGNITIVE DEFECT; DISEASE ASSOCIATION; DISEASE COURSE; ENDOSCOPIC SURGERY; FETUS DISEASE; FETUS RISK; FETUS SURGERY; FOLLOW UP; HUMAN; LAMINECTOMY; LONG TERM CARE; MENINGOMYELOCELE; MOTOR PERFORMANCE; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; CHILD; CHILD, PRESCHOOL; DISEASE MODELS, ANIMAL; FEMALE; FETOSCOPY; FOLLOW-UP STUDIES; GESTATIONAL AGE; HUMANS; INFANT; INFANT, NEWBORN; MENINGOMYELOCELE; MUSCLE, SKELETAL; POSTOPERATIVE COMPLICATIONS; PREGNANCY; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 83855164151     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/j.1469-8749.2011.04049.x     Document Type: Review

References (65)

1. Adzick NS, Harrison MR. Fetal surgical therapy. Lancet 1994; 343: 897-902.
2. Danzer E, Sydorak RM, Harrison MR, Albanese CT. Minimal access fetal surgery. Eur J Obstet Gynecol Reprod Biol 2003; 108: 3-13.
3. Deprest JA, Flake AW, Gratacos E, et al. The making of fetal surgery. Prenat Diagn 2010; 30: 653-67.
4. Adzick NS. Open fetal surgery for life-threatening fetal anomalies. Semin Fetal Neonatal Med 2010; 15: 1-8.
5. Adzick NS, Thom EA, Spong CY, et al. A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med 2011; 364: 993-1004.
6. Danzer E, Flake AW. In utero repair of myelomeningocele: rationale, initial clinical experience and a randomized controlled prospective clinical trial. Neuroembryol Ageing 20062007; 4: 165-74.
7. McLone DG, Dias MS. The Chiari II malformation: cause and impact. Childs Nerv Syst 2003; 19: 540-50.
8. Charney EB, Rorke LB, Sutton LN, Schut L. Management of Chiari II complications in infants with myelomeningocele. J Pediatr 1987; 111: 364-71.
9. Worley G, Schuster JM, Oakes WJ. Survival at 5years of a cohort of newborn infants with myelomeningocele. Dev Med Child Neurol 1996; 38: 816-22.
10. Oaks W, Gaskill S. Symptomatic Chiari malformations in childhood. In: Park TS, editor. Spinal Dysraphism. Boston: Blackwell Scientific Publications, 1992: 104-25.
11. Hoffman HJ, Neill J, Crone KR, Hendrick EB, Humphreys RP. Hydrosyringomyelia and its management in childhood. Neurosurgery 1987; 21: 347-51.
12. Dias MS, McLone DG. Hydrocephalus in the child with dysraphism. Neurosurg Clin North Am 1993; 4: 715-26.
13. Rintoul NE, Sutton LN, Hubbard AM, et al. A new look at myelomeningoceles: functional level, vetebral level, shunting, and the implication for fetal intervention. Pediatrics 2002; 109: 409-13.
14. Pooh RK, Shiota K, Kurjak A. Imaging of the human embryo with magnetic resonance imaging microscopy and high-resolution transvaginal 3-dimensional sonography: human embryology in the 21st century. Am J Obstet Gynecol 2011; 204: 77.e1-16.
15. Danzer E, Rintoul NE, Crombleholme TM, Adzick NS. Pathophysiology of neural tube defects. In: Pollin R, Fox WW, Abman SH, editors. Fetal and Neonatal Physiology, 3rd edn. Philadelphia: W.B. Saunders Company, 2003: 1772-85.
16. Mitchell LE, Adzick NS, Melchionne J, Pasquariello PS, Sutton LN, Whitehead AS. Spina bifida. Lancet 2004; 364: 1885-95.
17. Botto LD, Moore CA, Khoury MJ, Erickson JD. Neural-tube defects. N Engl J Med 1999; 341: 1509-19.
18. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992; 327: 1832-5.
19. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the medical research council vitamin study. Lancet 1991; 338: 131-7.
20. Williams LJ, Rasmussen SA, Flores A, Kirby RS, Edmonds LD. Decline in the prevalence of spina bifida and anencephaly by race/ethnicity: 1995-2002. Pediatrics 2005; 116: 580-6.
21. De Wals P, Tairou F, Van Allen MI, et al. Reduction in neural-tube defects after folic acid fortification in Canada. N Engl J Med 2007; 357: 135-42.
22. Hunt GM, Oakeshott P. Outcome in people with open spina bifida at age 35: prospective community based cohort study. BMJ 2003; 326: 1365-6.
23. Waitzman NJ, Romano PS, Scheffler RM. Estimates of the economic costs of birth defects. Inquiry 1994; 31: 188-205.
24. Patten B. Embryological stages in the establishing of myeloschisis with spina bifida. Am J Anat 1953; 93: 365-95.
25. Osaka K, Tanimura T, Hirayama A, Matsumoto S. Myelomeningocele before birth. J Neurosurg 1978; 49: 711-24.
26. Meuli M, Meuli-Simmen C, Hutchins GM, Seller MJ, Harrison MR, Adzick NS. The spinal cord lesion in human fetuses with myelomeningocele: implications for fetal surgery. J Pediatr Surg 1997; 31: 448-52.
27. Hutchins GM, Meuli M, Meuli-Simmen C, Jordan MA, Heffez DS, Blakemore KJ. Acquired spinal cord injury in human fetuses with myelomeningocele. Pediatr Path Lab Med 1996; 16: 701-12.
28. Sival DA, Guerra M, den Dunnen WF, et al. Neuroependymal denudation is in progress in full-term human foetal spina bifida aperta. Brain Pathol 2011; 21: 163-79.
29. Sival DA, Verbeek RJ, Brouwer OF, Sollie KM, Bos AF, den Dunnen WF. Spinal hemorrhages are associated with early neonatal motor function loss in human spina bifida aperta. Early Hum Dev 2008; 84: 423-31.
30. Sarnat HB. Ependymal reactions to injury. A review. J Neuropathol Exp Neurol 1995; 54: 1-15.
31. Korenromp MJ, Van Good JD, Bruinese HW, Kriek R. Early fetal movements in myelomeningocele. Lancet 1986; 1: 917-8.
32. Sival DA, Begeer JH, Staal-Schreinemachers AL, Vos-Niel JM, Beekhuis JR, Prechtl HF. Perinatal motor behaviour and neurological outcome in spina bifida aperta. Early Hum Dev 1997; 50: 27-37.
33. Luthy DA, Wardinsky T, Shurtleff DB, et al. Cesarean section before the onset of labour and subsequent motor function in infants with myelomeningocele diagnosed antenatally. N Engl J Med 1991; 324: 662-6.
34. Merrill DC, Goodwin P, Burson JM, Sato Y, Williamson R, Weiner CP. The optimal route of delivery for fetal myelomeningocele. Am J Obstet Gynecol 1998; 179: 235-40.
35. Copp AJ, Bernfield M. Aetiology and pathogenesis of human neural tube defects: insights from mouse models. Curr Opin Pediatr 1994; 6: 624-31.
36. Copp AJ, Greene ND, Murdoch JN. The genetic basis of mammalian neurulation. Nat Rev Genet 2003; 4: 784-93.
37. Ehlers K, Struje H, Merker HJ, Nau H. Spina bifida aperta induced by valproic acid and by all-trans-retinoic acid in the mouse: distinct differences in morphology and periods of sensitivity. Teratology 1992; 46: 117-30.
38. Michejda M. Intrauterine treatment of spina bifida: primate model. Z Kinderchir 1984; 39: 259-61.
39. Heffez DS, Aryanpur J, Rotellini NA, Hutchins GM, Freeman JM. Intrauterine repair of experimental surgically created dysraphism. Neurosurgery 1993; 32: 1005-10.
40. Heffez DS, Aryanpur J, Hutchins GM, Freeman JM. The paralysis associated with myelomeningocele: clinical and experimental data implicating a preventable spinal cord injury. Neurosurgery 1990; 26: 987-92.
41. Meuli M, Meuli-Simmen C, Yingling CD, et al. In utero surgery rescues neurological function at birth in sheep with spina bifida. Nat Med 1995; 1: 342-7.
42. Meuli M, Meuli-Simmen C, Hutchins GM, et al. In utero repair of experimental myelomeningocele spares neurological function at birth. J Pediatr Surg 1996; 31: 397-402.
43. Paek BW, Farmer DL, Wilkinson CC, et al. Hindbrain herniation develops in surgically created myelomeningocele but is absent after repair in fetal lambs. Am J Obstet Gynecol 2000; 183: 1119-23.
44. Bouchard S, Davey MG, Rintoul NE, Walsh DS, Rorke LB, Adzick NS. Correction of hindbrain herniation and anatomy of the vermis following in utero repair of myelomeningocele in sheep. J Pediatr Surg 2003; 38: 451-8.
45. Danzer E, Schwarz U, Wehrli S, Radu A, Adzick NS, Flake AW. Retinoic acid induced myelomeningocele in fetal rats: characterization by histopathological analysis and magnetic resonance imaging. Exp Neurol 2005; 194: 467-75.
46. Danzer E, Kiddoo DA, Redden RA, et al. Structural and functional characterization of bladder smooth muscle in fetal rats with retinoic acid induced myelomeningocele. Am J Physiol Renal Physiol 2007; 292: 197-206.
47. Danzer E, Radu A, Robinson LE, Volpe MV, Adzick NS, Flake AW. Morphologic analysis of the neuromuscular development of the anorectal unit in fetal rats with retinoic acid induced myelomeningocele. Neurosci Lett 2008; 430: 157-62.
48. Danzer E, Zhang L, Radu A, et al. Amniotic fluid levels of glial fibrillary acidic protein in fetal rats with retinoic acid induced myelomeningocele: a potential marker for spinal cord injury. Am J Obstet Gynecol 2011; 204: 178.e1-11.
49. Bruner J, Tulipan N, Richards W. Endoscopic coverage of fetal open myelomeningocele in utero. Am J Obstet Gynecol 1997; 176: 256-7.
50. Farmer DL, von Koch CS, Peacock WJ, et al. In utero repair of myelomeningocele: experimental pathophysiology, initial clinical experience, and outcomes. Arch Surg 2003; 138: 872-8.
51. Kohl T, Hering R, Heep A, et al. Percutaneous fetoscopic patch coverage of spina bifida aperta in the human - early clinical experience and potential. Fetal Diagn Ther 2006; 21: 185-93.
52. Kohl T, Tchatcheva K, Weinbach J, et al. Partial amniotic carbon dioxide insufflation (PACI) during minimally invasive fetoscopic surgery: early clinical experience in humans. Surg Endosc 2010; 24: 432-44.
53. Adzick NS, Sutton LN, Crombleholme TM, Flake AW. Successful fetal surgery for spina bifida. Lancet 1998; 352: 1675-6.
54. Sutton LN, Adzick NS, Bilaniuk LT, Johnson MP, Crombleholme TM, Flake AW. Improvement in hindbrain herniation demonstrated by serial fetal magnetic resonance imaging following fetal surgery for myelomeningocele. JAMA 1999; 282: 1826-31.
55. Bruner JP, Tulipan N, Paschall RL, et al. Fetal surgery for myelomeningocele and the incidence of shunt-dependent hydrocephalus. JAMA 1999; 282: 1819-25.
56. Johnson MP, Sutton LN, Rintoul N, et al. Fetal myelomeningocele repair: short-term clinical outcomes. Am J Obstet Gynecol 2003; 189: 482-7.
57. Danzer E, Johnson MP, Wilson RD, et al. Fetal head biometry following in-utero repair of myelomeningocele. Ultrasound Obstet Gynecol 2004; 24: 606-11.
58. Danzer E, Johnson MP, Bebbington M, et al. Fetal head biometry assessed by fetal magnetic resonance imaging following in utero myelomeningocele repair. Fetal Diagn Ther 2007; 22: 1-6.
59. Danzer E, Finkel RS, Rintoul NE, et al. Reversal of hindbrain herniation after maternal-fetal surgery for myelomeningocele subsequently impacts on brain stem function. Neuropediatrics 2008; 39: 359-62.
60. Danzer E, Finkel R, Gerdes M, et al. The relationship of seizure activity and chronic epilepsy in early infancy and short-term neurodevelopmental outcome following fetal myelomeningocele closure. Neuropediatrics 2010; 41: 140-3.
61. Danzer E, Gerdes M, Bebbington MW, et al. Lower extremity neuromotor function and short-term ambulatory potential following in utero myelomeningocele surgery. Fetal Diagn Ther 2009; 25: 47-53.
62. Danzer E, Adzick NS, Rintoul NE, et al. Intradural inclusion cysts following in utero closure of myelomeningocele: clinical implications and follow-up findings. J Neurosurg Pediatr 2008; 2: 406-13.
63. Danzer E, Gerdes M, Bebbington MW, Zarnow DM, Adzick NS, Johnson MP. Preschool neurodevelopmental outcome of children following fetal myelomeningocele closure. Am J Obstet Gynecol 2010; 202: 450.e1-9.
64. Wilson RD, Johnson MP, Flake AW, et al. Reproductive outcomes after pregnancy complicated by maternal-fetal surgery. Am J Obstet Gynecol 2004; 191: 1430-6.
65. Watanabe M, Jo J, Radu A, Kaneko M, Tabata Y, Flake AW. A tissue engineering approach for prenatal closure of myelomeningocle with gelatin sponges incorporating basic fibroblast growth factor. Tissue Eng Part A 2010; 16: 1645-55.